CBIO
Crescent Biopharma
CBIO
CBIO
47 hedge funds and large institutions have $64.9M invested in Crescent Biopharma in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 20 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
55% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 20
67% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 15
Holders
47
Holding in Top 10
–
Calls
$1.08M
Puts
$763K
Top Buyers
| 1 | +$598K | |
| 2 | +$352K | |
| 3 | +$119K | |
| 4 |
D.E. Shaw & Co
New York
|
+$112K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$78.8K |
Top Sellers
| 1 | -$601K | |
| 2 | -$522K | |
| 3 | -$511K | |
| 4 |
E
Ergoteles
New York
|
-$373K |
| 5 |
Renaissance Technologies
New York
|
-$354K |